MEN1 (GeneName), Menin (ProteinName), MEN1_HUMAN.
Human MEN1/ Menin ELISA Kit
Natural and recombinant human Menin
Serum, plasma, tissue homogenates, cell culture supernates and other biological fluids
Component of the MLL-HCF complex, at least composed of KMT2A/MLL1, MEN1, ASH2L, RBBP5, DPY30, WDR5, HCFC1 and HCFC2. Component of the menin-associated histone methyltransferase complex, at least composed of KMT2B/MLL4, MEN1, ASH2L, RBBP5, DPY30 and WDR5. Interacts with POLR2B. Interacts with POLR2A phosphorylated at 'Ser-5', but not with the unphosphorylated, nor 'Ser-2' phosphorylated POLR2A forms. Interacts with FANCD2 and DBF4. Interacts with JUND. Interacts with SMAD3, but not with SMAD2, nor SMAD4. Directly interacts with NFKB1, NFKB2 and RELA.
Essential component of a MLL/SET1 histone methyltransferase (HMT) complex, a complex that specifically methylates 'Lys-4' of histone H3 (H3K4). Functions as a transcriptional regulator. Binds to the TERT promoter and represses telomerase expression. Plays a role in TGFB1-mediated inhibition of cell-proliferation, possibly regulating SMAD3 transcriptional activity. Represses JUND-mediated transcriptional activation on AP1 sites, as well as that mediated by NFKB subunit RELA. Positively regulates HOXC8 and HOXC6 gene expression. May be involved in normal hematopoiesis through the activation of HOXA9 expression (By similarity). May be involved in DNA repair.
Nucleus Concentrated in nuclear body-like structures. Relocates to the nuclear matrix upon gamma irradiation.
MGLKAAQKTL | FPLRSIDDVV | RLFAAELGRE | EPDLVLLSLV | LGFVEHFLAV |
NRVIPTNVPE | LTFQPSPAPD | PPGGLTYFPV | ADLSIIAALY | ARFTAQIRGA |
VDLSLYPREG | GVSSRELVKK | VSDVIWNSLS | RSYFKDRAHI | QSLFSFITGW |
SPVGTKLDSS | GVAFAVVGAC | QALGLRDVHL | ALSEDHAWVV | FGPNGEQTAE |
VTWHGKGNED | RRGQTVNAGV | AERSWLYLKG | SYMRCDRKME | VAFMVCAINP |
SIDLHTDSLE | LLQLQQKLLW | LLYDLGHLER | YPMALGNLAD | LEELEPTPGR |
PDPLTLYHKG | IASAKTYYRD | EHIYPYMYLA | GYHCRNRNVR | EALQAWADTA |
TVIQDYNYCR | EDEEIYKEFF | EVANDVIPNL | LKEAASLLEA | GEERPGEQSQ |
GTQSQGSALQ | DPECFAHLLR | FYDGICKWEE | GSPTPVLHVG | WATFLVQSLG |
RFEGQVRQKV | RIVSREAEAA | EAEEPWGEEA | REGRRRGPRR | ESKPEEPPPP |
KKPALDKGLG | TGQGAVSGPP | RKPPGTVAGT | ARGPEGGSTA | QVPAPTASPP |
PEGPVLTFQS | EKMKGMKELL | VATKINSSAI | KLQLTAQSQV | QMKKQKVSTP |
SDYTLSFLKR | QRKGL
This product has not yet been referenced specifically in any publications.
"Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age?"
"Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition."
"Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas."
"Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression."
"Functional interaction between tumor suppressor menin and activator of S-phase kinase."
"Menin associates with FANCD2, a protein involved in repair of DNA damage."
"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study."
"The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation."
"Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling."
"Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1."
Displaying results : 0
No feedback yet, let's comment.
Product Name *
Size Quantity Price ($) Subtotal 1 ($)
Subtotal 2: $
Size Quantity Price ($)
Do you want to be our agent and get a lower discount?
Please contact us:
Please contact us: